tradingkey.logo
tradingkey.logo
Suchen

Bio-Techne Corp

TECH
Zur Watchlist hinzufügen
71.000USD
0.0000.00%
Handelsschluss 06/26, 16:00ETKurse um 15 Minuten verzögert
11.07BMarktkapitalisierung
100.60KGV TTM

mehr Informationen über Bio-Techne Corp Unternehmen

Bio-Techne Corporation develop, manufacture and sell life science reagents, instruments and services for the research, diagnostics and bioprocessing markets worldwide. The Company’s segments include Protein Sciences segment and Diagnostics and Spatial Biology segment. The Protein Sciences segment is a developer and manufacturer of biological reagents used in all aspects of life science research, diagnostics and cell and gene therapy. The Diagnostics and Spatial Biology segment develops and manufactures diagnostic products, including controls, calibrators, and diagnostic assays for the regulated diagnostics market, advanced tissue-based in-situ hybridization assays and instrumentation for spatial genomic and tissue biopsy analysis and genetic and oncology kits for research and clinical applications. Its product portfolio and application enable scientific investigations into biological processes and molecular diagnostics and progression of specific diseases.

Bio-Techne Corp Informationen

BörsenkürzelTECH
Name des UnternehmensBio-Techne Corp
IPO-datumFeb 09, 1989
CEOKelderman (Kim)
Anzahl der mitarbeiter3100
WertpapierartOrdinary Share
GeschäftsjahresendeFeb 09
Addresse614 Mckinley Pl N E
StadtMINNEAPOLIS
BörseNASDAQ OMX - NASDAQ BASIC
LandUnited States of America
Postleitzahl55413
Telefon16123798854
Websitehttps://www.bio-techne.com/
BörsenkürzelTECH
IPO-datumFeb 09, 1989
CEOKelderman (Kim)

Führungskräfte von Bio-Techne Corp

Name
Name/Position
Position
Aktienbesitz
Veränderung
Mr. John L. Higgins
Mr. John L. Higgins
Independent Director
Independent Director
66.88K
+2.45%
Mr. Kim Kelderman
Mr. Kim Kelderman
President, Chief Executive Officer, Director
President, Chief Executive Officer, Director
65.80K
+4.17%
Mr. Robert V. (Bob) Baumgartner, CPA
Mr. Robert V. (Bob) Baumgartner, CPA
Independent Chairman of the Board
Independent Chairman of the Board
46.50K
+3.53%
Dr. Joseph D. (Joe) Keegan, Ph.D.
Dr. Joseph D. (Joe) Keegan, Ph.D.
Independent Director
Independent Director
15.41K
+10.64%
Dr. Rupert J. Vessey, Ph.D.
Dr. Rupert J. Vessey, Ph.D.
Independent Director
Independent Director
10.99K
+14.93%
Ms. Julie L. Bushman
Ms. Julie L. Bushman
Independent Director
Independent Director
8.78K
+18.69%
Mr. Shane Bohnen
Mr. Shane Bohnen
Senior Vice President, General Counsel, Corporate Secretary
Senior Vice President, General Counsel, Corporate Secretary
7.25K
+18.55%
Dr. Judith V. Klimovsky, M.D.
Dr. Judith V. Klimovsky, M.D.
Independent Director
Independent Director
3.78K
+43.36%
Mr. James T. (Jim) Hippel
Mr. James T. (Jim) Hippel
Chief Financial Officer, Executive Vice President - Finance
Chief Financial Officer, Executive Vice President - Finance
--
--
Mr. David Clair
Mr. David Clair
Investor Relations
Investor Relations
--
--
Mehr Anzeigen
Name
Name/Position
Position
Aktienbesitz
Veränderung
Mr. John L. Higgins
Mr. John L. Higgins
Independent Director
Independent Director
66.88K
+2.45%
Mr. Kim Kelderman
Mr. Kim Kelderman
President, Chief Executive Officer, Director
President, Chief Executive Officer, Director
65.80K
+4.17%
Mr. Robert V. (Bob) Baumgartner, CPA
Mr. Robert V. (Bob) Baumgartner, CPA
Independent Chairman of the Board
Independent Chairman of the Board
46.50K
+3.53%
Dr. Joseph D. (Joe) Keegan, Ph.D.
Dr. Joseph D. (Joe) Keegan, Ph.D.
Independent Director
Independent Director
15.41K
+10.64%
Dr. Rupert J. Vessey, Ph.D.
Dr. Rupert J. Vessey, Ph.D.
Independent Director
Independent Director
10.99K
+14.93%
Ms. Julie L. Bushman
Ms. Julie L. Bushman
Independent Director
Independent Director
8.78K
+18.69%

Häufig gestellte Fragen

Wer sind die fünf größten Anteilseigner von Bio-Techne Corp?

Die fünf größten Anteilseigner von Bio-Techne Corp sind: Mr. John L. Higgins

Wie viele Institutionen halten Anteile an Bio-Techne Corp (TECH)?

Mit Stand vom 2026Q1 halten 1247 Institutionen Anteile an Bio-Techne Corp, mit einem Gesamtmarktwert von etwa 178.19M, was 113.81% der Gesamtanteile entspricht. Im Vergleich zum 2025Q4 ist der institutionelle Aktienbesitz um 1433.00 gestiegen.

Was ist die größte Einnahmequelle von Bio-Techne Corp?

Am 2026Q1 erzielte das Geschäft mit Consumables für Bio-Techne Corp den höchsten Umsatz in Höhe von 235.44M, was 79.57% des Gesamtumsatzes entspricht.
KeyAI